Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.

about

Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.

Item

http://www.wikidata.org/entity/Q40107697

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Direct-acting antiviral agent ...... ion: A PRISMA-compliant study.

@en

type

Item

label

Direct-acting antiviral agent ...... ion: A PRISMA-compliant study.

@en

prefLabel

Direct-acting antiviral agent ...... ion: A PRISMA-compliant study.

@en

P1476

Direct-acting antiviral agent ...... ion: A PRISMA-compliant study.

@en

P2093

Jiexiu Zhang

http://www.w3.org/2001/XMLSchema#string

Keliang Chen

http://www.w3.org/2001/XMLSchema#string

Min Gu

http://www.w3.org/2001/XMLSchema#string

Pei Lu

http://www.w3.org/2001/XMLSchema#string

Rijin Song

http://www.w3.org/2001/XMLSchema#string

Rongzhen Tao

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Zijie Wang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Sofosbuvir for previously untreated chronic hepatitis C infection

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.

Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

P304

e7568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1097/MD.0000000000007568

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28746204

http://www.w3.org/2001/XMLSchema#string

P932

5627830

http://www.w3.org/2001/XMLSchema#string